An evaluation of glycosylated hemoglobin requesting patterns in a primary care setting: A pilot experience in the Valencian Community (Spain);Evaluación del patrón de solicitud de hemoglobina glucosilada por Atención Primaria: Estudio piloto regional en la Comunidad Valenciana

Endocrinologia y Nutricion

Volumn 58, Issue 5, 2011, Pages 219-223

  Salinas, María ^a   López Garrigós, Maite ^a   Carratala, Arturo ^b   Aguado, Cristina ^c   Díaz, Julián ^d   Ortuño, Mario ^e   Rodriguez Borja, Enrique ^b   Yago, Martín ^f   Chinchilla, Virtudes ^g   Marcaida, Goizane ^h   Esteban, Ángel ^g   Laíz, Begoña ^c   Guaita, Marcos ^h   Lorente, Miguel Ángel ⁱ   Pomares, Francisco ^a   Uris, Joaquín ^j  

^a HOSPITAL UNIVERSITARIO DE SAN JUAN   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^c HOSPITAL UNIVERSITARIO LA FE   (Spain)

^d Hospital Francesc Borja   (Spain)

^e HOSPITAL DE LA RIBERA   (Spain)

^f Hospital de Requena   (Spain)

^g HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^h HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

ⁱ Roche Diagnostics ^*  (Spain)

^j UNIVERSITY OF ALICANTE   (Spain)

more..

Author keywords

Biological markers; Glycemic control; Glycosylated hemoglobin; Type 2 diabetes mellitus

Indexed keywords

HEMOGLOBIN A1C;

ARTICLE; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; HEALTH CARE FACILITY; HEMOGLOBIN ANALYSIS; HUMAN; PILOT STUDY; PREVALENCE; PRIMARY MEDICAL CARE; PUBLIC HEALTH SERVICE; SPAIN;

CROSS-SECTIONAL STUDIES; HEMATOLOGIC TESTS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PILOT PROJECTS; PRIMARY HEALTH CARE; SPAIN;

EID: 79955760032     PISSN: 15750922     EISSN: 15792021     Source Type: Journal    
DOI: 10.1016/j.endonu.2011.02.009     Document Type: Article

References (17)

1. Sacks D.B., Bruns D.E., Goldstein D.E., Maclaren N.K., McDonald J.M., Parrott M. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2002, 48:436-472.
2. Manley S. Haemoglobin A1c-a marker for complications of type 2 diabetes: the experience from the UK Prospective Diabetes Study (UKPDS). Clin Chem Lab Med 2003, 41:1182-1190.
3. Goldstein D.E., Little R.R., Lorenz R.A., Malone J.I., Nathan D., Peterson C.M., et al. Test of glycemia in diabetes. Diabetes Care 2004, 27:1761-1773.
4. Van Walraven C., Raymod M. Population-based study of repeat laboratory testing. Clin Chem 2003, 19:1997-2005.
5. International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes. Diabetes Care 2009, 32:1327-1334. International Expert Committee.
6. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010, 33:S62-69. American Diabetes Association.
7. Rius Riu F. La hemoglobina glucosilada como criterio diagnóstico de diabetes mellitus. Endocrinol Nutr 2010, 57:12712-12719.
8. Álvarez-García E. HbA1c, estandarización y expresión de resultados. Endocrinol Nutr 2010, 57:177-181.
9. Catalá MJ, Catalá M, Girbés J, Lluch I, Sanz J, Bataller A. Prevalencia de diabetes y síndrome metabólico en la Comunidad Valenciana. " Estudio Valencia" Plan de Diabetes de la Comunidad Valenciana 2006-2010. Generalitat Valenciana, Conselleria de Sanitat 2006.
10. Edelman D., Olsen M.K., Dudley T.K., Harris A.C., Oddone E.Z. Utility of hemoglobin A1c in predicting diabetes risk. J Gen Intern Med 2004, 19:1175-1180.
11. Pradhan A.D., Rifai N., Buring J.E., Ridker P.M. Hemoglobin A1c predicts diabetes but not cardiovascular disease in nondiabetic women. Am J Med 2007, 120:720-727.
12. Sato K.K., Hayashi T., Harita N., Yoneda T., Nakamura Y., Endo G., et al. Combined measurement of fasting plasma glucose and A1c is effective for the prediction of type 2 diabetes. The Kansay Healthcare Study. Diabetes Care 2009, 32:644-646.
13. Wilson S.E., Lipscome L.L., Rosella L.C., Manuel D.G. Trends in laboratory testing for diabetes in Ontario, Canada 1995-2005: A population-based study. BMC Health Serv Res 2009, 9:41.
14. Lyon A.W., Higgins T., Wesenberg J.C., Tran D.V., Cembrowski C.S. Variation in frequency of hemoglobin A1c (HbA1c) testing: population studies used to assess compliance with clinical practice guidelines and use of HbA1c to screen for diabetes. J Diabetes Sci Technol 2009, 3:411-417.
15. Benito López P., García Mayor R., Puig Domingo M., Mesa Manteca J., Pallardo Sánchez L.F., Faure Nogueras E., et al. Pathological characteristics of patients with diabetes mellitus type 2, in Spanish Primary Care. Rev Clin Esp 2004, 204:18-24.
16. Mengual L., Roura P., Serra M., Montasell M., Prieto G., Bonet S. Multifactorial control and treatment intensity of type-2 diabetes in primary care settings in Catalonia. Cardiovasc Diabetol 2010, 9:14.
17. Screening for type 2 diabetes. Diabetes Care 2004, 27:S11-14. American Diabetes Association.